LJI Wealth Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7K | Sell |
19,760
-4,000
| -17% | -$2.17K | ﹤0.01% | 185 |
|
|
2025
Q1 | $15.6K | Sell |
23,760
-500
| -2% | -$328 | ﹤0.01% | 182 |
|
|
2024
Q4 | $24.7K | Sell |
24,260
-1,800
| -7% | -$1.84K | ﹤0.01% | 179 |
|
|
2024
Q3 | $22.6K | Sell |
26,060
-10,100
| -28% | -$8.75K | ﹤0.01% | 190 |
|
|
2024
Q2 | $13K | Sell |
36,160
-4,100
| -10% | -$1.47K | ﹤0.01% | 184 |
|
|
2024
Q1 | $27K | Sell |
40,260
-3,900
| -9% | -$2.61K | 0.01% | 151 |
|
|
2023
Q4 | $24K | Buy |
44,160
+1,600
| +4% | +$869 | 0.01% | 168 |
|
|
2023
Q3 | $25.5K | Sell |
42,560
-7,550
| -15% | -$4.53K | 0.01% | 160 |
|
|
2023
Q2 | $65.1K | Buy |
50,110
+11,000
| +28% | +$14.3K | 0.02% | 170 |
|
|
2023
Q1 | $68.8K | Sell |
39,110
-12,500
| -24% | -$22K | 0.02% | 156 |
|
|
2022
Q4 | $162K | Buy |
+51,610
| New | +$162K | 0.06% | 141 |
|